The FDA has approved Skinvive by Juvéderm for the improvement of neck appearance, marking the first and only FDA-cleared hyaluronic acid filler indicated for this specific area. The approval opens a new treatment category for medspa and aesthetic practice owners, addressing a common patient concern that has historically relied on off-label use or alternative modalities.

Skinvive joins Allergan Aesthetics' flagship portfolio alongside Botox and traditional Juvéderm products. The indication expands the injectable toolkit for practices already stocked with Juvéderm, allowing practitioners to address neck lines and skin quality in a single visit.